[Criteria for choosing treatment of multiple sclerosis]

Therapeutic options for multiple sclerosis (MS) have expanded considerably, allowing for increasingly individualized management. In 2026, disease-modifying therapies include immunomodulators, oral immunosuppressants, and monoclonal antibodies. Therapeutic strategies are tailored to disease course and severity, treatment-related risks, and patient characteristics such as age, pregnancy plans, comorbidities. Intravenous corticosteroid therapy is the standard treatment for flare-ups. Management of symptoms particularly pain, urinary dysfunction, and cognitive impairment, most often relies on a multidisciplinary approach involving both medical and paramedical care. When managing complex situations, seeking the advice of an MS Resource and Competence Center (MS RCC) is particularly helpful.